HealthAratus Intelligence

Akili Interactive

Akili Interactive
Akili Interactive Intelligence Room

Akili Interactive Intelligence

What the accumulated evidence, deployment record and lived experience actually show.

Intelligence lenses

Four ways of interrogating the same reality. Each changes the question, not the subject.

Do published findings about Akili Interactive match what happens in practice?

  • Public evidence

    Clinical validation of AI hip measurement tool HIPPO in European study

    SignalHunt:validation:ImageBiopsy Lab

  • Public evidence

    GlaukomAI: Clinical Validation of an AI System for Early Glaucoma Screening

    ClinicalTrials.gov AI

  • Public evidence

    AI-Based Digital Therapeutics vs. Traditional Schroth Exercises for Adolescent Idiopathic Scoliosis

    ClinicalTrials.gov AI

  • Public evidence

    Osteoboost Health Raises $8M for FDA-Cleared Bone Density Device

    HIT Consultant

  • Public evidence

    From Insight to Intervention: Why Over-the-Counter Digital Therapeutics (ODTx) are the Next Step for LLMs and Wearables

    MedCity News

What we know · what we don’t

Everything here is open to being corrected by someone who has seen it first-hand.

What we still don’t know

Nobody has answered these yet. Your experience can help us understand what is happening.

Unresolved

We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.

Not yet answered

What are we missing?

Matters of record

Settled elsewhere. Context for reading the above, not something practice can confirm.

  • 5 public external signal(s) across 4 source(s).Recorded by HealthAratus

Tool intelligence

What HealthAratus understands

HealthAratus currently understands Akili Interactive through regulatory records, a published study, company records and external market activity.

Category
mental-health-behavioral-health

What HealthAratus is still learning

HealthAratus is beginning to understand Akili Interactive. As evidence and experience accumulate, what remains unclear will be stated here.

Evidence & claims

What this is built on

The material the questions above were built from, with its attribution.

Akili Interactive develops prescription video game treatments designed to improve attention function. The technology uses mobile game experiences to target neural systems related to attentional control.According to Akili Interactive

What Akili Interactive states

The vendor’s own claims. Testable where practice can actually test them.

Stated capability

The digital treatment improves attention function in patients.

According to Akili Interactive

Does this change your workflow?

Independent and public evidence

Found in public sources. Not a clinician’s experience, and never presented as one.

Reported deployment

AI-Based Digital Therapeutics vs. Traditional Schroth Exercises for Adolescent Idiopathic Scoliosis

According to ClinicalTrials.gov AI

How widely is this actually used?

Reported deployment

From Insight to Intervention: Why Over-the-Counter Digital Therapeutics (ODTx) are the Next Step for LLMs and Wearables

According to MedCity News

How widely is this actually used?

Reported outcome

Clinical validation of AI hip measurement tool HIPPO in European study

Reported publicly

Are you seeing this result?

Reported outcome

GlaukomAI: Clinical Validation of an AI System for Early Glaucoma Screening

According to ClinicalTrials.gov AI

Are you seeing this result?

Recent change

Osteoboost Health Raises $8M for FDA-Cleared Bone Density Device

According to HIT Consultant

A matter of record — context, not something practice can confirm.

Company participation

Not yet verified

A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.

Claim your company profile

Reference

The stable facts, for interpreting everything above.

Overview

What it does

• Akili Interactive is a digital therapeutics company specializing in prescription video game treatments for cognitive impairments. Their flagship product, EndeavorRx®, is FDA-cleared for children aged 8-12 with ADHD, marking the first video game-based prescription treatment for this condition.…

Vendor & external product information, not independently verified by HealthAratus

Where it's used

Deployed in mixed settings, US, Europe, Asia-Pacific

Key strength

Regulatory: FDA-cleared, CE Mark

Key capabilities

Prescription video game treatments for cognitive impairments, FDA-cleared digital therapeutics for ADHD, Proprietary SSME™ technology targeting attentional control

Clinical use cases

Treatment of pediatric ADHD with EndeavorRx®, Development of attention-improving games for children with TALi Digital, Potential treatment for cognitive dysfunction in ASD, MS, and MDD patients

Who uses it

Children aged 8-12 with ADHD, Adults with ADHD, Children with ASD

Parent Company
Akili Interactivevendor
1 tracked tool

How the reality here has changed

Not enough recorded activity across time yet to describe how the reality here has moved. As accounts of Akili Interactive accumulate, this becomes a record of how the reality moved rather than a snapshot of one moment.

Connected intelligence